7. Bibliografía

1. Lindstrom PA. Prefrontal ultrasonic irradiation: a substitute for lobotomy. Arch Neurol Psych. 1954;72:399-425.

2. Fry W, Barnard J, Fry F, Krumins R, Brennan J. Ultrasonic lesions in the mammalian central nervous system with ultrasound. Science. 1955;122:517-8.

3. Fry WJ, Mosberg WH Jr, Barnard JW, Fry FJ. Production of focal destructive lesions in the central nervous system with ultrasound. J Neurosurg. 1954;11:471-8.

4. Lizzi FL, Coleman DJ, Driller J, Franzen LA, Jakobiec FA. Experimental, ultrasonically induced lesions in the retina, choroid, and sclera. Invest Ophthalmol Vis Sci. 1978;17:350-60.

5. Lizzi FL, Coleman DJ, Driller J, Franzen LA, Leopold M. Effects of pulsed ultrasound Figura 7. Interposición de asas y cicatriz abdominal. on ocular tissue. Ultrasound Med Biol. 1981;7:245-52.

6. Coleman DJ, Lizzi FL, Driller J, Rosado AL, Chang S, Iwamoto T, et al. Therapeutic ultrasound in the treatment of glaucoma. I. Experimental model. Ophthalmology. 1985;92:339-46.

7. Tempany CM, Stewart EA, McDannold N, Quade BJ, Jolesz FA, Hynynen K. MR imaging-guided focused ultrasound surgery of uterine leiomyomas: a feasibility study. Radiology. 2003;226:897-905.

8. Stewart E, Gedroyc W, Tempany C, Quade B, Inbar Y, Ehrenstein T, et al. Focused ultrasound treatment of uterine fibroid tumors: Safety and feasibility of a non invasive tecnique. Am J Obstet Gynecol. 2003;189:48-54.

9. Ter Haar GR. Ultrasound biophysics. En: Hill CR, Bamber JC, Haar GR, editors. Physical principles of medical ultrasonics: ultrasonic biophysics. 2nd ed. New York: Wiley; 2004. p. 349-406.

10. Vaecy S, Andrew M, Kaczkowski P, Crum L. Image-guided acoustic terapy. Annu Rev Biomed Eng. 2001;3:375-90.

11. Wu F, Chen WZ, Bai J, Zou JZ, Wang ZL, Zhu H, et al. Pathological changes in human malignant carcinoma treated with high-intensity focused ultrasound. Ultrasound Med Biol. 2001;27:1099-106.

12. Van leenders GJ, Beerlage HP, Ruijter ET, De la Rosette JJ, Van de Kaa CA. Histopathological changes associated with high intensity focused ultrasound /HIFU) treatment for localised adenocarcinoma of the prostate. J Clin Pathol. 2000;53:391-4.

13. Hill CR, Rivens I Vaughan MG, Ter Haar GR. Lesion developement in focused ultrasound surgery: a general model. Ultrasound Med Biol. 1994;20:259-69.

18. Furusawa H, Namba K, Thomsen S, Akiyama F, Bendet A, Tanaka C, et alt. Magnetic resonance-guided focused ultrasound surgery of breast cancer. J Am Coll Surg. 2006;203:54-63.

14. Muto S, Yoshii T, Saito K, Kamiyama Y, Ide H, Horie S. Focal therapy with high intensity focused ultrasound in the treatment of localized prostate cancer. Jpn J Clin Oncol. 2008;38:192-99.

15. Wu F, Wang ZB, Chen WZ, Wang W, Gui Y, Zhang M, et al. Extracorporeal high intensity focused ultrasound ablation in the treatment of 1038 patients with solid carcinomas in China: an overview. Ultrason Sonochem. 2004;11:149-54.

16. Wu F, Want ZB, Zhu H, Chen WZ, Zou JZ, Bai J, et al. Feasibility of US-guided highintensity focused ultrasound treatment in patients with advanced pancreatic cancer: initial experience. Radiology. 2005;236:1034-40.

17. Chen W, Zhu H, Zhang L, Li K, Su H, Zhou K, et al. Primary bone malignancy : effective treatment with high-intensity focused ultrasound ablation. Radology. 2010;255:967-78.

18. Esnault O, Franc B, Ménégaux F, Rouxel A, Kerviler E, Bourrier P, et al. High-intensity focused ultrasound ablation of thyroid nodules: first human feasibility study. Thyroid. 2011;21:965-73.

19. Kovatcheva RD, Vlahov JD, Stoinov JI, Kirilov GG, Krivosshiev SG, Arnaud F, et al. High-intensity focused ultrasound (HIFU) treatment in uraemic secundary hyperparathyroidism. Nephrol Dial Transplant. 2012;27:76-80.

20. Helsey JK, Gorny KR, Woodrum DA. MR-guided focused ultrasound for the treatment of uterine fibroids. Cardiovasc Intervent Radiol. 2013;6:5-13.

21. www.myomainstitute.com

22. www.edap-hifu.com

23. www.haifu.com.cn

24. www.insigtech.com

25. Shehata IA. Treatment with high intensity focused ultrasound: Secrets revealed. Eur J Radiol. 2012;81:534-41.

26. Spies JB, Coyne K, Guaou Guaou N, Boyle D, Skyrnarz-Murphy K, Gonzalves SM. The UFS-QOL, a new disease-specific symptom and health-related quality of life.

27. Harding G, Coyne KS, Thompson CL, Spies JB. The responsiveness of the uterine fibroid symptom and health-related quality of life questionnaire (UFS-QOL). Health Qual Life Outcomes. 2008;6:99.

28. Stamatopoulos CP, Mikos T, Grimbizis GF, Dimitriadis AS, Efstratiou I, Stamatopoulos P, et al. Value of magnetic resonance imaging in diagnosis of adenomyosis and myomas of the uterus. J Minim Invasive Gynecol. 2012;19:620-6.

29. Stewart EA, Geodryc WM, Tempany CM, Quade BJ, Inbar Y, Ehrenstein T, et alt. Focused ultrasound treatment of uterine fibroid tumors: safety and feasibility of non invasive thermoablative technique. Am J Obstet Gynecol. 2003;189:48-54.

30. Stewart EA, Rabinovici J, Tempany CM, Inbar Y, Regan L, Gostout B, et alt. Clinical outcomes of focused ultrasound surgery of uterine fibroids. Fertil Steril. 2006;85:22-9.

31. Smart OC, Hindley JT,Regan L, Gedroyc WG. Gonadotrophin-releasing hormone and magnetic-resonance-guided ultrasound surgery for uterine leiomyomata. Obstet Gynecol. 206;108:49-54.

32. Smart OC, Hindley JT, Regan L, Gedroyc WG. Magnetic resonance guided focused ultrasound surgery of uterine fibroids. The tissue effects of GnRh agonist pretreatment. Eur J Radiol. 2006;59:163-67.

33. Wang W, Wang Y, Wang T, Wang J, Wang L, Tang J. Safety and efficacy of US-guided high-intensity focused ultrasound for treatment of submucusal fibroids. Eur Radiol. 2012;22:2553-8.

34. Hindley J, Gedroyc WM, Regan L, Stewart E, Tempany C, Hynyen K, et alt. MRI guidance of focused ultrasound therapy of uterine fibroids: early results. AJR Am J Roentgenol. 2004;183:1713-9.

35. Funaki K, Fukunishi H, Funaki T, Sawada K, Kaji Y, Maruo T. Magnetic reso- nanceguided focused ultrasound surgery for uterine fibroids: relationship between the therapeutic effects and signal intensity of preexisting T2-weighted magnetic resonance images. Am J Obstet Gynecol. 2007;196:e181-6.

36. Zhao WP, Chen JY, Zhang L, Li Q, Qin J, Peng S, et al. Feasibility of ultrasound-guided high intensity focused ultrasound ablating uterine fibroids with hyperintense on T2-weighted MR imaging. Eur J Radiol. 2013;82:e43-9.

37. Zaher S, Gedroyc W, Lyons D, Regan L. A novel method to aid in the visualitation an tratment of uterine fibroids with MRgFUS in patients with abdominal scars. Eur J Radiol. 2010;76:269-73.

38. Zhang L, Chen WZ, Liu YJ, Hu X, Zhou K, Chen L, et al. Feasibility of magnetic resonance imaging-guided high intensity focused ultrasound therapy for ablating uterine fibroids in patients with bowel lies anterior to the uterus. Eur J Radiol.2010;73:396-403.

39. Rabinovici J, David M, Fukunishi H, Morita Y, Gostout BS, Stewart EA; MRgFUS Study Group. Pregnancy outcome after magnetic resonance-guided focused ultrasound surgery (MRgFUS) for conservative treatment of uterine fibroids. Fertil Steril. 2010;93:199-209.

40. Qin J, Chen JY, Zhao WP, Hu L, Chen WZ, Wang ZB. Outcome of unintended pregnancy after ultrasound-guided high-intensity focused ultrasound ablation of uterine fibroids. Int J Gynaecol Obstet. 2012;117:273-7.

41. Stewart E, Rabinovici J, Tempany C, Inbar Y Regan L, Gastoud B, et al. Clinical outcomes of focused ultrasond surgery for the tretment of uterine fibroids. Fertil Steril. 2006;85:22-9.

42. Zowall H, Cairns B, Brewer C, Lamping DL, Gedroyc W, Regan L. Cost-effectiveness of magnetic resonance-guided focused surgery for treatment of uterine fibroids. Br J Obstet Gynaecol. 2008;115:653-62.

Contáctanos si deseas recibir más información:

* Campos obligatorios

Top